NSE filing, NSE: BLISSGVS. Summary written from the filing by ALFA Finder's alert engine.
Bliss GVS Pharma Ltd: key numbers
- Share price
- ₹680.90
- Market cap
- ₹7,244 Cr
- Revenue (annual)
- ₹927.1 Cr
- Net profit (annual)
- ₹129.1 Cr
- P/E (TTM)
- 53.2×Sector 46.1×
- Promoter holding
- 50.07%+15.06% QoQ
- FII holding
- 5.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bliss GVS Pharma Ltd
All →Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bliss GVS Pharma Board Meeting Date
Bliss GVS Pharma Ltd scheduled a board meeting for October 29, 2026, to approve the company's unaudited financial results for the quarter ending September 30, 2026.
Bliss GVS Pharma Other Announcement
Bliss GVS Pharma Ltd has filed its quarterly shareholding pattern report for the period ended September 30, 2026.
Bliss GVS Pharma Annual General Meeting
Bliss GVS Pharma has issued a postal ballot notice to seek member approval for the appointment of three directors. This follows a recent change in control.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma Limited allotted 53,500 equity shares under its Employee Stock Option Plan (ESOP). This issuance increases the company's total paid-up share capital.
Bliss GVS Pharma Promoter Reclassification
Bliss GVS Pharma announced the reclassification of its erstwhile promoter group to the public category following a change in control via an open offer.
Other board meeting date announcements
All →Virat Industries Board Meeting Date
Brahm Virat Industries has scheduled a board meeting for November 5, 2026, to approve Q2 and H1 FY2027 results. Trading window closure began October 1, 2026.
Betex India Board Meeting Date
Betex India scheduled a board meeting for 4 Nov 2026 to approve un-audited Q1 and H1 FY27 results. No financial figures are disclosed in this advance intimation.
Trade Wings Board Meeting Date
Trade Wings Ltd has scheduled a board meeting on 13 November 2026 to consider Q2 FY27 unaudited financial results. No decisions have been made yet.
Multibase India Board Meeting Date
Multibase India intimated that its Board meeting is scheduled for 04 Nov 2026 to consider un-audited financial results for Q1/H1 FY27. No monetary figures or material decisions are announced.
AUDROC Board Meeting Date
Audroc Ltd intimated a Board meeting on November 3, 2026, to approve Q2 and H1 unaudited financial results. The trading window for designated persons is closed.
Max heights Infrastucture Board Meeting Date
Max Heights Infrastructure has intimated a board meeting on 5 November 2026 to approve unaudited financial results for Q1 and H1 FY27. No results or figures are disclosed in this advance notice.